Insights into the antibacterial and immunomodulatory functions of tilapia hepcidin (TH)2-3 against Vibrio vulnificus infection in mice

Developmental and Comparative Immunology

Volumn 36, Issue 1, 2012, Pages 166-173

  Pan, Chieh Yu ^a   Lee, Shang Chun ^b   Rajanbabu, Venugopal ^b   Lin, Cheng Hui ^a   Chen, Jyh Yih ^b  

^a NATIONAL TAIWAN OCEAN UNIVERSITY   (Taiwan)

^b INSTITUTE OF CELLULAR AND ORGANISMIC BIOLOGY   (Taiwan)

Author keywords

Antimicrobial peptide; Curative treatments; Hepcidin; Immunomodulatory function; Prophylaxis; Vibrio vulnificus

Indexed keywords

GAMMA INTERFERON; HEPCIDIN; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 4; MONOCYTE CHEMOTACTIC PROTEIN 1; NEUTRALIZING ANTIBODY; TETRACYCLINE; TILAPIA HEPCIDIN 2-3; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBACTERIAL ACTIVITY; ANTIBODY BLOOD LEVEL; ARTICLE; BACTERIAL IMMUNITY; BACTERIOSTASIS; CELL PROLIFERATION; CONTROLLED STUDY; HOST RESISTANCE; IMMUNIZATION; IMMUNOMODULATION; INFECTION CONTROL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS; SURVIVAL RATE; TIME SERIES ANALYSIS; TREATMENT DURATION; VIBRIO VULNIFICUS; VIBRIO VULNIFICUS INFECTION;

BACTERIA (MICROORGANISMS); MUS; TILAPIA; VIBRIO VULNIFICUS;

EID: 80054952863     PISSN: 0145305X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dci.2011.06.013     Document Type: Article

References (31)

1. Bachère E., Gueguen Y., Gonzalez M., de Lorgeril J., Garnier J., Romestand B. Insights into the anti-microbial defense of marine invertebrates: the penaeid shrimps and the oyster Crassostrea gigas. Immunol. Rev. 2004, 198:149-168.
2. Bubonja M., Wraber B., Brumini G., Gobin I., Veljkovic D., Abram M. Systemic and local CC chemokines production in a murine model of Listeria monocytogenes infection. Mediators Inflamm. 2006, 2006(3):54202.
3. Camaschella C. Understanding iron homeostasis through genetic analysis of hemochromatosis and related disorders. Blood 2005, 106(12):3710-3717.
4. Gombart A.F., Borregaard N., Koeffler H.P. Human cathelicidin antimicrobial peptide (CAMP) gene is a direct target of the vitamin D receptor and is strongly up-regulated in myeloid cells by 1, 25-dihydroxyvitamin D3. FASEB J. 2005, 19(9):1067-1077.
5. Hsieh J.C., Pan C.Y., Chen J.Y. Tilapia hepcidin (TH)2-3 as a transgene in transgenic fish enhances resistance to Vibrio vulnificus infection and causes variations in immune-related genes after infection by different bacterial species. Fish Shellfish Immunol. 2010, 29(3):430-439.
6. Huang P.H., Chen J.Y., Kuo C.M. Three different hepcidins from tilapia, Oreochromis mossambicus: analysis of their expressions and biological functions. Mol. Immunol. 2007, 44(8):1922-1934.
7. Kim S.Y., Shin S., Koo H.C., Youn J.H., Paik H.D., Park Y.H. In vitro antimicrobial effect and in vivo preventive and therapeutic effects of partially purified lantibiotic lacticin NK34 against infection by Staphylococcus species isolated from bovine mastitis. J. Dairy Sci. 2010, 93(8):3610-3615.
8. Lee B.C., Kim S.H., Choi S.H., Kim T.S. Induction of interleukin-8 production via nuclear factor-kappaB activation in human intestinal epithelial cells infected with Vibrio vulnificus. Immunology 2005, 115(4):506-515.
9. Lee J.C., Greenwich J.L., Zhanel G.G., Han X., Cumming A., Saward L., McLoughlin R.M. Modulation of the local neutrophil response by a novel hyaluronic acid-binding peptide reduces bacterial burden during staphylococcal wound infection. Infect. Immun. 2010, 78(10):4176-4186.
10. Lu Z.Q., Li M.F., Qiu Q.M., Liang H., Zhou T.L., Hong G.L., Wu B. Effect of antimicrobial agents on the toll-like receptors and inflammatory cytokines in liver tissue of the alcohol-induced liver disease in rats with Vibrio vulnificus sepsis. Chin. Med. J. (Engl.) 2009, 122(16):1910-1916.
11. Mai V., Ukhanova M., Visone L., Abuladze T., Sulakvelidze A. Bacteriophage administration reduces the concentration of Listeria monocytogenes in the gastrointestinal tract and its translocation to spleen and liver in experimentally infected mice. Int. J. Microbiol. 2010, 2010:624234.
12. Mantur B., Parande A., Amarnath S., Patil G., Walvekar R., Desai A., Parande M., Shinde R., Chandrashekar M., Patil S. ELISA versus conventional methods of diagnosing endemic brucellosis. Am. J. Trop. Med. Hyg. 2010, 83(2):314-318.
13. Malik R., Manocha A., Suresh D.K. Photodynamic therapy - a strategic review. Indian J. Dent. Res. 2010, 21(2):285-291.
14. Mookherjee N., Brown K.L., Bowdish D.M., Doria S., Falsafi R., Hokamp K., Roche F.M., Mu R., Doho G.H., Pistolic J., Powers J.P., Bryan J., Brinkman F.S., Hancock R.E. Modulation of the TLR-mediated inflammatory response by the endogenous human host defense peptide LL-37. J. Immunol. 2006, 176(4):2455-2464.
15. Morrow M.P., Yan J., Pankhong P., Ferraro B., Lewis M.G., Khan A.S., Sardesai N.Y., Weiner D.B. Unique Th1/Th2 phenotypes induced during priming and memory phases by use of interleukin-12 (IL-12) or IL-28B vaccine adjuvants in rhesus macaques. Clin. Vaccine Immunol. 2010, 17(10):1493-1499.
16. Mueller L., Seggern L.V., Schumacher J., Goumas F., Wilms C., Braun F., Broering D.C. TNF-alpha similarly induces IL-6 and MCP-1 in fibroblasts from colorectal liver metastases and normal liver fibroblasts. Biochem. Biophys. Res. Commun. 2010, 397:586-591.
17. Mutoh H., Sashikawa M., Hayakawa H., Sugano K. Monocyte chemoattractant protein-1 is generated via TGF-beta by myofibroblasts in gastric intestinal metaplasia and carcinoma without H. pylori infection. Cancer Sci. 2010, 101(8):1783-1789.
18. Osorio J.E., Powell T.D., Frank R.S., Moss K., Haanes E.J., Smith S.R., Rocke T.E., Stinchcomb D.T. Recombinant raccoon pox vaccine protects mice against lethal plague. Vaccine 2003, 21(11-12):1232-1238.
19. Otero-González A.J., Magalhães B.S., Garcia-Villarino M., López-Abarrategui C., Sousa D.A., Dias S.C., Franco O.L. Antimicrobial peptides from marine invertebrates as a new frontier for microbial infection control. FASEB J. 2010, 24(5):1320-1334.
20. Rajanbabu V., Pan C.Y., Lee S.C., Lin W.J., Lin C.C., Li C.L., Chen J.Y. Tilapia hepcidin 2-3 peptide modulates lipopolysaccharide-induced cytokines and inhibits tumor necrosis factor-alpha through cyclooxygenase-2 and phosphodiesterase 4D. J. Biol. Chem. 2010, 285(40):30577-30586.
21. Rodriguez C.A., Agudelo M., Zuluaga A.F., Vesga O. In vitro and in vivo comparison of the anti-staphylococcal efficacy of generic products and the innovator of oxacillin. BMC Infect. Dis. 2010, 10:153.
22. Rosenstiel P., Philipp E.E., Schreiber S., Bosch T.C. Evolution and function of innate immune receptors-insights from marine invertebrates. J. Innate Immun. 2009, 1(4):291-300.
23. Schmid J.A., Birbach A. IkappaB kinase beta (IKKbeta/IKK2/IKBKB) - a key molecule in signaling to the transcription factor NF-kappaB. Cytokine Growth Factor Rev. 2008, 19:157-165.
24. Sonoda K.H., Yoshimura T., Egashira K., Charo I.F., Ishibashi T. Neutrophil-dominant experimental autoimmune uveitis in CC-chemokine receptor 2 knockout mice. Acta Ophthalmol. 2010, 89:e180-e188.
25. Stephanou A. Role of STAT-1 and STAT-3 in ischaemia/reperfusion injury. J. Cell Mol. Med. 2004, 8:519-525.
26. Tesniere A., Abermil N., Schlemmer F., Casares N., Kepp O., Pequignot M., Michaud M., Martins I., Senovilla L., Zitvogel L., Kroemer G. In vivo depletion of T lymphocyte-specific transcription factors by RNA interference. Cell Cycle 2010, 9(14):2830-2835.
27. Tincu J.A., Taylor S.W. Antimicrobial peptides from marine invertebrates. Antimicrob. Agents Chemother 2004, 48(10):3645-3654.
28. Toma C., Higa N., Koizumi Y., Nakasone N., Ogura Y., McCoy A.J., Franchi L., Uematsu S., Sagara J., Taniguchi S., Tsutsui H., Akira S., Tschopp J., Núñez G., Suzuki T. Pathogenic Vibrio activate NLRP3 inflammasome via cytotoxins and TLR/nucleotide-binding oligomerization domain-mediated NF-kappa B signaling. J. Immunol. 2010, 184(9):5287-5297.
29. Wu Y., Zhang Q., Sales D., Bianco A.E., Craig A. Vaccination with peptide mimotopes produces antibodies recognizing bacterial capsular polysaccharides. Vaccine 2010, 28(39):6425-6435.
30. Yeaman M.R., Yount N.Y. Mechanisms of antimicrobial peptide action and resistance. Pharmacol. Rev. 2003, 55(1):27-55.
31. Zhang X., Song Y., Ci X., An N., Ju Y., Li H., Wang X., Han C., Cui J., Deng X. Ivermectin inhibits LPS-induced production of inflammatory cytokines and improves LPS-induced survival in mice. Inflamm. Res. 2008, 57(11):524-529.